Ação interferente do ácido ascórbico no doseamento da glicose sérica e urinária e do ácido úrico sérico, in vitro

Rodrigues, Élcio R Rodrigues; Pedrazi, Antenor Henrique Pinto; Franco, João José; Zanardo Filho, Antonio.
Rev. bras. anal. clin ; 29(4): 220-222, 1997. tab, graf
Artículo en Portugués | LILACS | ID: lil-525255

Documentos relacionados

  1. Outcome-based analytical performance specifications: current status and future challenges.
  2. The harmonization issue in laboratory medicine: the commitment of <i>CCLM</i>.
  3. The effect of unintended shortage in technical resources on the quality of endpoint clinical laboratory diagnosis.
  4. Responses to "Health Canada needs to act on laboratory-developed diagnostics".
  5. Challenges Associated with the Effective Implementation of New Laboratory Tests-The International Experience.
  6. AWMF statement on medical services in laboratory diagnostics and pathology with regard to the IVDR.
  7. APS calculator: a data-driven tool for setting outcome-based analytical performance specifications for measurement uncertainty using specific clinical requirements and population data.
  8. [Catch-Up Seminar for Laboratory Medicine: Now and in the Future Overview of the Guidelines from the Japanese Society of Laboratory Medicine (JSLM 2015) -For Post 2017-].
  9. Documenting and validating metrological traceability of serum alanine aminotransferase measurements: a priority for medical laboratory community for providing high quality service in hepatology.
  10. [LABORATORY TESTS AND RADIOLOGICAL IMAGING - DIAGNOSTIC TOOLS THAT SHARE INFORMATION AND CAN BE FUNCTIONALLY INTEGRATED].